[1] Compton JG, DiGiovanna JJ, Santucci SK, et al. Linkage of epidermolytic hyperkeratosis to the type Ⅱ keratin gene cluster on chromosome 12q. Nat Genet, 1992,1:301-305. [2] Bonifas JM, Bare JW, Chen MA, et al. Linkage of the epidermolytic hyperkeratosis phenotype and the region of the type Ⅱ keratin gene cluster on chromosome 12. J Invest Dermatol, 1992,99:524-573. [3] Fuchs E, Esteves RA, Coulombe PA. Transgenic mice expressing a mutant keratin 10 gene reveal the likely genetic basis for epidermolytic hyperkeratosis. Proc Natl Acad Sci USA, 1992,89:6906-6910. [4] 朱学骏,陈喜雪,李冠群,等.角蛋白相关遗传性皮肤病基因突变的研究进展.中华皮肤科杂志,2001,34:403-404. [5] Steinert PM. Structure, function, and dynamics of keratin intermediate filaments. J Invest Dermatol, 1993,100:729-734. [6] Syder AJ, Yu QC, Paller AS, et al. Genetic mutations in the K1 and K10 genes of patients with epidermolytic hyperkeratosis. Correlation between location and disease severity. J Clin Invest, 1994,93:1533-1542. [7] 李冠群,吴安,马玲蕾,等.聚合酶链反应-DNA测序检测大疱型先天性鱼鳞病样红皮病家系角蛋白K10基因点突变.中华皮肤科杂志,1997,30:374-376. [8] Yang JM, Nam K, Kim HC, et al. A novel glutamic acid to aspartic acid mutation near the end of the 2B rod domain in the keratin 1 chain in epidermolytic hyperkeratosis. J Invest Dermatol, 1999,112:376-379. [9] Wu KC, Bryan JT, Morasso MI, et al. Coiled-coil trigger motifs in the 1B and 2B rod domain segments are required for the stability of keratin intermediate filaments. Mol Biol Cell, 2000,11:3539-3958. |